| Phenotype and functions of conventional and non-conventional NK cells TK Erick, L Brossay Current opinion in immunology 38, 67-74, 2016 | 49 | 2016 |
| Role of type I interferon receptor signaling on NK cell development and functions J Guan, SMS Miah, ZS Wilson, TK Erick, C Banh, L Brossay PLoS One 9 (10), e111302, 2014 | 35 | 2014 |
| NFIL3 expression distinguishes tissue-resident NK cells and conventional NK-like cells in the mouse submandibular glands TK Erick, CK Anderson, EC Reilly, JR Wands, L Brossay The Journal of Immunology 197 (6), 2485-2491, 2016 | 32 | 2016 |
| Preclinical evaluation of an 111In/225Ac theranostic targeting transformed MUC1 for triple negative breast cancer VJ Kelly, ST Wu, V Gottumukkala, R Coelho, K Palmer, S Nair, T Erick, ... Theranostics 10 (15), 6946, 2020 | 30 | 2020 |
| Inflammation-induced lactate leads to rapid loss of hepatic tissue-resident NK cells G Dodard, A Tata, TK Erick, D Jaime, SMS Miah, L Quatrini, B Escalière, ... Cell reports 32 (1), 2020 | 28 | 2020 |
| Potential immunotherapeutic targets for hypoxia due to COVI-Flu Y Leyfman, TK Erick, SS Reddy, S Galwankar, PWB Nanayakkara, ... Shock 54 (4), 438-450, 2020 | 24 | 2020 |
| HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implications P Tarantino, SM Niman, TK Erick, N Priedigkeit, BT Harrison, A Giordano, ... European Journal of Cancer 174, 277-286, 2022 | 16 | 2022 |
| The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II–III and metastatic breast cancers KS Anderson, TK Erick, M Chen, H Daley, M Campbell, Y Colson, M Mihm, ... Breast cancer research and treatment 194 (1), 65-78, 2022 | 16 | 2022 |
| Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice JM Curry, DM Besmer, TK Erick, N Steuerwald, L Das Roy, P Grover, ... PLoS One 14 (11), e0224309, 2019 | 15 | 2019 |
| Das Roy JM Curry, DM Besmer, TK Erick, N Steuerwald L., Grover, P., Rao, S., Nath, S., Ferrier JW, Reid, RW & Mukherjee, P, 2019 | 11 | 2019 |
| Cancer and COVID-19: unravelling the immunological interplay with a review of promising therapies against severe SARS-CoV-2 for cancer patients Y Leyfman, N Emmanuel, GP Menon, M Joshi, WB Wilkerson, J Cappelli, ... Journal of Hematology & Oncology 16 (1), 39, 2023 | 4 | 2023 |
| Perceptions of patients with early stage breast cancer toward research biopsies DS Seah, JP Leone, TH Openshaw, SM Scott, N Tayob, J Hu, ... Cancer 127 (8), 1208-1219, 2021 | 3 | 2021 |
| Modulating MUC1 function on T cells TK Erick, P Mukherjee Trends in immunology 40 (11), 980-983, 2019 | 3 | 2019 |
| Dendritic cell-based cancer therapies: current status and future directions SM Shahjahan Miah, TK Erick, DF Emerich Cell Therapy: Current Status and Future Directions, 99-120, 2017 | 2 | 2017 |
| Perceptions of patients and medical oncologists toward biospecimen donation in the setting of abnormal breast imaging findings DS Seah, N Tayob, JP Leone, J Hu, J Yin, M Hughes, SM Scott, ... Breast Cancer Research and Treatment 192 (1), 201-210, 2022 | 1 | 2022 |
| Lacrimal gland NK cells are developmentally and functionally similar to conventional NK cells TK Erick, L Grigoryan, L Brossay Immunohorizons 1 (2), 2-9, 2017 | 1 | 2017 |
| Abstract PS12-06: A phase 2 study of abemaciclib monotherapy for patients with retinoblastoma-positive (Rb+), triple-negative metastatic breast cancer S Goel, B Jovanović, X Chu, M Hughes, A Mohammed-Abreu, ... Cancer Research 84 (9_Supplement), PS12-06-PS12-06, 2024 | | 2024 |
| HER2-low inflammatory breast cancer (IBC): Clinicopathologic features and prognostic implications P Tarantino, SL Niman, T Erick, N Priedigkeit, B Harrison, A Giordano, ... ANNALS OF ONCOLOGY 33 (7), S629-S630, 2022 | | 2022 |
| Cancer and COVID-19: A proposed mechanism with therapeutic interventions. Y Leyfman, N Emmanuel, A Tentler, J Cappelli, TK Erick, P Sharma, ... Journal of Clinical Oncology 39 (15_suppl), 3135-3135, 2021 | | 2021 |
| Kinetics of the liver resident NK cell compartment G Dodard, T Erick, A Tata, L Brossay The Journal of Immunology 200 (1_Supplement), 116.17-116.17, 2018 | | 2018 |
